Day J P, Lanas A, Rustagi P, Hirschowitz B I
Division of Gastroenterology, University of Alabama at Birmingham 35294, USA.
J Clin Gastroenterol. 1996 Mar;22(2):96-103. doi: 10.1097/00004836-199603000-00004.
The purpose of this research was to look for a possible mechanism whereby NSAIDs, and particularly ASA, might cause gastrointestinal bleeding. A total of 34 hospitalized GI bleeders and 29 age- and sex-matched controls were studied. Skin bleeding time (SBT) was measured within 6 h of coming to hospital and before any blood products were given. All patients and controls were questioned regarding current NSAID use. This history was supplemented by estimation of serum salicylate and of platelet cyclooxygenase activity to detect unreported current aspirin (ASA) use. Various aspects of platelet function were also tested by lumiaggregation in 28 controls and, after recovery, in 27 of the bleeders. Of 34 bleeders, 26 bled from the upper GI tract, (13 from peptic ulcer) and eight from the lower GI tract, 30 (88%) had a current intake of NSAIDs and of these 22 (73%) used ASA, some in combination with other NSAIDs, whereas 12 of 29 controls were using NSAID's, 11 of which were ASA. SBT in the bleeders was 9.0 +/- 1.02 min versus 4.8 +/- 0.42 min in the controls (p < 0.001). SBT measured 6.6 days later in 28 bleeders was 4.7 +/- 0.22 min (p < 0.0006), and of those tested after recovery all but one had fallen to 6.5 min or less. None had any residual constitutional platelet abnormalities as tested by lumiaggregation. By logistic regression, NSAID intake was strongly associated with prolonged SBT to > 6 min (odds ratio [OR], 16.7; p < 0.0002), whereas NSAID intake (OR 14.6; p < 0.0003) and SBT > 6 min (OR 1.8; p < 0.005) contributed to a bleeding outcome. Almost 90% of GI bleeders had recently consumed NSAIDs, mostly ASA, on an average 15 h before onset of bleeding. Although most of the nonbleeders who had used NSAIDs did not have a prolonged SBT, most of the bleeders who used NSAIDs had an abnormal elevation of SBT, suggesting a possible mechanism for GI bleeding. Retesting approximately 7 days after recovery from bleeding showed normalization of the SBT, indicating that the defect was transient and spontaneously reversible.
本研究的目的是寻找非甾体抗炎药(NSAIDs),尤其是阿司匹林(ASA)可能导致胃肠道出血的潜在机制。共研究了34例住院的胃肠道出血患者和29例年龄及性别匹配的对照者。在入院后6小时内且未给予任何血液制品之前测量皮肤出血时间(SBT)。所有患者和对照者均被询问当前NSAIDs的使用情况。通过测定血清水杨酸和血小板环氧化酶活性来补充这一病史,以检测未报告的当前阿司匹林(ASA)使用情况。还通过光聚集法对28例对照者以及27例出血患者康复后进行了血小板功能的各项检测。34例出血患者中,26例为上消化道出血(13例来自消化性溃疡),8例为下消化道出血,30例(88%)当前正在服用NSAIDs,其中22例(73%)使用ASA,部分患者同时服用其他NSAIDs,而29例对照者中有12例正在使用NSAIDs,其中11例为ASA。出血患者的SBT为9.0±1.02分钟,而对照者为4.8±0.42分钟(p<0.001)。28例出血患者在6.6天后测量的SBT为4.7±0.22分钟(p<0.0006),康复后接受检测的患者中,除1例之外,其余所有患者的SBT均降至6.5分钟或更短。通过光聚集法检测,无一例患者存在残留的先天性血小板异常。通过逻辑回归分析,服用NSAIDs与SBT延长至>6分钟密切相关(比值比[OR]为16.7;p<0.0002),而服用NSAIDs(OR为14.6;p<0.0003)和SBT>6分钟(OR为1.8;p<0.005)均与出血结局相关。几乎90%的胃肠道出血患者近期服用过NSAIDs,主要是ASA,平均在出血发作前15小时。虽然大多数使用过NSAIDs的非出血者SBT未延长,但大多数使用NSAIDs的出血者SBT异常升高,提示可能存在胃肠道出血的机制。出血康复后约7天重新检测显示SBT恢复正常,表明该缺陷是短暂的且可自发逆转。